Guangzhou Medical University
Clinical trials sponsored by Guangzhou Medical University, explained in plain language.
-
New hope for brain lining cancer: spinal tap chemo after targeted drug fails
Disease control Recruiting nowThis study tests a chemotherapy drug called pemetrexed, given directly into the spinal fluid, for people with a specific type of lung cancer that has spread to the lining of the brain and spinal cord. The cancer has stopped responding to a higher dose of a targeted therapy. The g…
Phase: PHASE2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for deadly breast cancer complication: drug combo enters human trials
Disease control Recruiting nowThis study tests a combination of two drugs—sacituzumab govitecan (given through a vein) and pemetrexed (given into the spinal fluid)—for people with HER2-negative breast cancer that has spread to the lining of the brain and spinal cord (leptomeningeal metastases). The goal is to…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Promising combo therapy for brain metastases in lung cancer patients
Disease control Recruiting nowThis study tests whether adding a chemotherapy drug (pemetrexed) given directly into the spinal fluid to a standard targeted therapy pill (like osimertinib) works better than the pill alone for lung cancer that has spread to the brain and spine. About 100 adults with a specific g…
Phase: NA • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC